NHNSEQ3 FY24December 31, 2023

Narayana Hrudayalaya Ltd.

2,507words
0turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
ecretary Listing Department BSE Limited Department of Corporate Services Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 Scrip Code – 539551 Dear Sir/Madam, To, The Secretary Listing
rs 4,193
d 100+ Clinical Specialty & Sub-Specialty 19,002 Full-time Employees & Associates including doctors 4,193 Doctors (1) Owns the P&L responsibility (2) Based on (Gross Block for Fixed Assets (adjusted for no
50%
11-year-old presented with super refractory status epilepticus which has an expected mortality of 50% & expected disability of 80% was treated with Novel High dose Phenobarb therapy for 3 weeks. The p
80%
uper refractory status epilepticus which has an expected mortality of 50% & expected disability of 80% was treated with Novel High dose Phenobarb therapy for 3 weeks. The patient recovered without any
INR 12,036
Robotic Ortho procedures​ ​. Clinical & Operational • • • Consolidated operating revenues of INR 12,036 mn in Q3 FY24, an increase of 6.7% YoY and decrease of 7.8% QoQ Consolidated EBITDA of INR 2,968 mn
6.7%
Operational • • • Consolidated operating revenues of INR 12,036 mn in Q3 FY24, an increase of 6.7% YoY and decrease of 7.8% QoQ Consolidated EBITDA of INR 2,968 mn in Q3 FY24 translating into EBITD
7.8%
onsolidated operating revenues of INR 12,036 mn in Q3 FY24, an increase of 6.7% YoY and decrease of 7.8% QoQ Consolidated EBITDA of INR 2,968 mn in Q3 FY24 translating into EBITDA margin of 24.7% and con
INR 2,968
INR 12,036 mn in Q3 FY24, an increase of 6.7% YoY and decrease of 7.8% QoQ Consolidated EBITDA of INR 2,968 mn in Q3 FY24 translating into EBITDA margin of 24.7% and consolidated PAT of INR 1,881 mn at a PAT
24.7%
rease of 7.8% QoQ Consolidated EBITDA of INR 2,968 mn in Q3 FY24 translating into EBITDA margin of 24.7% and consolidated PAT of INR 1,881 mn at a PAT margin of 15.6% Consolidated Total Borrowings less C
INR 1,881
d EBITDA of INR 2,968 mn in Q3 FY24 translating into EBITDA margin of 24.7% and consolidated PAT of INR 1,881 mn at a PAT margin of 15.6% Consolidated Total Borrowings less Cash, Bank Balance and Current Inves
15.6%
Y24 translating into EBITDA margin of 24.7% and consolidated PAT of INR 1,881 mn at a PAT margin of 15.6% Consolidated Total Borrowings less Cash, Bank Balance and Current Investments was - INR 251 mn (Ne
INR 251
argin of 15.6% Consolidated Total Borrowings less Cash, Bank Balance and Current Investments was - INR 251 mn (Net Cash) as on 31st December, 2023 i.e., net debt to equity ratio of - 0.01 (out of which, debt
Advertisement
← All transcriptsNH stock page →